Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
18 July, 2018 10:38 IST
Jubilant Life Sciences gets final nod for Niacin ER tablets
Source: IRIS | 15 May, 2018, 03.28PM
Comments  |  Post Comment

Jubilant Life Sciences, an integrated global Pharmaceutical and Life Sciences Company, has announced that Jubilant Pharma, a material wholly owned subsidiary of the company, through one of its wholly owned subsidiaries, has received Abbreviated New Drug Application (ANDA) final approval for Niacin Extended-Release Tablets USP, 500 mg, 750 mg, and 1,000 mg, the generic version of Niaspan of AbbVie, which is indicated to reduce elevated TC, LDLC, Apo B and TG, and to increase HDL-C in patients with primary hyperlipidemia and mixed dyslipidemia thereby reducing the risk of recurrent nonfatal myocardial infarction in patients with a history of myocardial infarction and hyperlipidemia.

This is the first approval that we have received from the USFDA during the current financial year. As on March 31, 2018, Jubilant (Q,N,C,F)* had a total of 94 ANDAs for Oral Solids filed in the US, of which 59 had been approved and 12 Sterile (Injectables & Ophthlamics) filings, of which 10 had been approved.

Shares of the company declined Rs 20.9, or 2.48%, to trade at Rs 822.65. The total volume of shares traded was 29,580 at the BSE (3.13 p.m., Tuesday).



Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Zee Entertainment Enterprises quarterly earnings up 31% - 17-Jul-2018 15:53
NBCC receives Rs 4 bn order from Govt of India - 17-Jul-2018 12:21
Zydus Cadila gets approval for Clindamycin Phosphate topical solution - 17-Jul-2018 11:08
Fitch affirms Indian Oil Corporation at 'BBB-'; outlook stable - 17-Jul-2018 10:31
Temporary trading halt on MCX on July 16, 2018 - 17-Jul-2018 10:25
SSWL gets 18,000 wheels order from European after market - 17-Jul-2018 10:20
Larsen & Tubro arm secures onshore EPC contract from HPCL-Mittal Energy - 17-Jul-2018 10:08
Adani Logistics to form JV with NYK Auto Logistics - 17-Jul-2018 09:55
Glenmark Pharma gets USFDA's nod for Colesevelam HCl - 17-Jul-2018 09:46
L&T, BEML ink MoU to address indigenisation needs of Indian defence market - 16-Jul-2018 17:43
L&T, BEML ink MoU to address indigenisation needs of Indian defence market - 16-Jul-2018 17:43
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer